Analysis of solute clearance and flux in pre- and post-dilution hemofiltration

M. R. Pillarella, Andrew Zydney

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hemofiltration, or blood ultrafiltration, is a pressure-driven process used to remove waste solutes and excess water from blood in the treatment of kidney dysfunction. This convective process provides better removal of middle molecular weight solutes (1,000-20,000 MW) than hemodialysis, substantially reducing the incidence of hypotension. The ultrafiltration is performed using a cross-flow configuration in which blood flow is parallel to the filtering membrane and perpendicular to the filtrate flow. This configuration minimizes the accumulation of retained species at the membrane surface, significantly increasing filtration rates. Clinical hemofiltration is performed in two distinct modes: post-dilution, in which the fluid removed during filtration is replaced after blood leaves the filter, and pre-dilution, in which the replacement fluid is added to the blood before it enters the filter. Although post-dilution is used more commonly, the high hematocrit at the device outlet limits the maximum attainable flux and can contribute to cell damage. The lower inlet hematocrit and plasma protein concentration in pre-dilution leads to a marked increase in flux, potentially increasing the removal of waste solutes. There is, however, a concomitant increase in the amount of diluting fluid required and in the amount of fluid that must be removed during filtration. Existing models for hemofiltration are unable to explain the complicated dependence of the filtrate flux on shear rate, hematocrit, and plasma protein concentration. These models cannot be used to accurately compare the performance of different devices or of the two clinical modalities. The authors have recently developed a detailed theoretical model for filtrate flux in hemofiltration that explicitly includes the effects of both red cell and plasma protein polarization. The authors apply this model to the analysis of clinical hemofiltration devices, including the effects of pre- and post-dilution on solute clearance.

Original languageEnglish (US)
Pages (from-to)415-419
Number of pages5
JournalASAIO Transactions
Volume34
Issue number3
StatePublished - Jan 1 1988

Fingerprint

Hemofiltration
Dilution
Fluxes
Blood
Hematocrit
Blood Proteins
Ultrafiltration
Fluids
Equipment and Supplies
Proteins
Plasmas
Cells
Membranes
Parallel flow
Hypotension
Renal Dialysis
Theoretical Models
Shear deformation
Molecular Weight
Kidney

All Science Journal Classification (ASJC) codes

  • Biophysics

Cite this

@article{437d385f58fc44c898faba2ba41751a3,
title = "Analysis of solute clearance and flux in pre- and post-dilution hemofiltration",
abstract = "Hemofiltration, or blood ultrafiltration, is a pressure-driven process used to remove waste solutes and excess water from blood in the treatment of kidney dysfunction. This convective process provides better removal of middle molecular weight solutes (1,000-20,000 MW) than hemodialysis, substantially reducing the incidence of hypotension. The ultrafiltration is performed using a cross-flow configuration in which blood flow is parallel to the filtering membrane and perpendicular to the filtrate flow. This configuration minimizes the accumulation of retained species at the membrane surface, significantly increasing filtration rates. Clinical hemofiltration is performed in two distinct modes: post-dilution, in which the fluid removed during filtration is replaced after blood leaves the filter, and pre-dilution, in which the replacement fluid is added to the blood before it enters the filter. Although post-dilution is used more commonly, the high hematocrit at the device outlet limits the maximum attainable flux and can contribute to cell damage. The lower inlet hematocrit and plasma protein concentration in pre-dilution leads to a marked increase in flux, potentially increasing the removal of waste solutes. There is, however, a concomitant increase in the amount of diluting fluid required and in the amount of fluid that must be removed during filtration. Existing models for hemofiltration are unable to explain the complicated dependence of the filtrate flux on shear rate, hematocrit, and plasma protein concentration. These models cannot be used to accurately compare the performance of different devices or of the two clinical modalities. The authors have recently developed a detailed theoretical model for filtrate flux in hemofiltration that explicitly includes the effects of both red cell and plasma protein polarization. The authors apply this model to the analysis of clinical hemofiltration devices, including the effects of pre- and post-dilution on solute clearance.",
author = "Pillarella, {M. R.} and Andrew Zydney",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "34",
pages = "415--419",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Analysis of solute clearance and flux in pre- and post-dilution hemofiltration. / Pillarella, M. R.; Zydney, Andrew.

In: ASAIO Transactions, Vol. 34, No. 3, 01.01.1988, p. 415-419.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analysis of solute clearance and flux in pre- and post-dilution hemofiltration

AU - Pillarella, M. R.

AU - Zydney, Andrew

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Hemofiltration, or blood ultrafiltration, is a pressure-driven process used to remove waste solutes and excess water from blood in the treatment of kidney dysfunction. This convective process provides better removal of middle molecular weight solutes (1,000-20,000 MW) than hemodialysis, substantially reducing the incidence of hypotension. The ultrafiltration is performed using a cross-flow configuration in which blood flow is parallel to the filtering membrane and perpendicular to the filtrate flow. This configuration minimizes the accumulation of retained species at the membrane surface, significantly increasing filtration rates. Clinical hemofiltration is performed in two distinct modes: post-dilution, in which the fluid removed during filtration is replaced after blood leaves the filter, and pre-dilution, in which the replacement fluid is added to the blood before it enters the filter. Although post-dilution is used more commonly, the high hematocrit at the device outlet limits the maximum attainable flux and can contribute to cell damage. The lower inlet hematocrit and plasma protein concentration in pre-dilution leads to a marked increase in flux, potentially increasing the removal of waste solutes. There is, however, a concomitant increase in the amount of diluting fluid required and in the amount of fluid that must be removed during filtration. Existing models for hemofiltration are unable to explain the complicated dependence of the filtrate flux on shear rate, hematocrit, and plasma protein concentration. These models cannot be used to accurately compare the performance of different devices or of the two clinical modalities. The authors have recently developed a detailed theoretical model for filtrate flux in hemofiltration that explicitly includes the effects of both red cell and plasma protein polarization. The authors apply this model to the analysis of clinical hemofiltration devices, including the effects of pre- and post-dilution on solute clearance.

AB - Hemofiltration, or blood ultrafiltration, is a pressure-driven process used to remove waste solutes and excess water from blood in the treatment of kidney dysfunction. This convective process provides better removal of middle molecular weight solutes (1,000-20,000 MW) than hemodialysis, substantially reducing the incidence of hypotension. The ultrafiltration is performed using a cross-flow configuration in which blood flow is parallel to the filtering membrane and perpendicular to the filtrate flow. This configuration minimizes the accumulation of retained species at the membrane surface, significantly increasing filtration rates. Clinical hemofiltration is performed in two distinct modes: post-dilution, in which the fluid removed during filtration is replaced after blood leaves the filter, and pre-dilution, in which the replacement fluid is added to the blood before it enters the filter. Although post-dilution is used more commonly, the high hematocrit at the device outlet limits the maximum attainable flux and can contribute to cell damage. The lower inlet hematocrit and plasma protein concentration in pre-dilution leads to a marked increase in flux, potentially increasing the removal of waste solutes. There is, however, a concomitant increase in the amount of diluting fluid required and in the amount of fluid that must be removed during filtration. Existing models for hemofiltration are unable to explain the complicated dependence of the filtrate flux on shear rate, hematocrit, and plasma protein concentration. These models cannot be used to accurately compare the performance of different devices or of the two clinical modalities. The authors have recently developed a detailed theoretical model for filtrate flux in hemofiltration that explicitly includes the effects of both red cell and plasma protein polarization. The authors apply this model to the analysis of clinical hemofiltration devices, including the effects of pre- and post-dilution on solute clearance.

UR - http://www.scopus.com/inward/record.url?scp=0023698891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023698891&partnerID=8YFLogxK

M3 - Article

C2 - 3196540

AN - SCOPUS:0023698891

VL - 34

SP - 415

EP - 419

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -